Table:
|  | Year ended December 31, |  |
| --- | --- | --- |
|  | 2018 | 2019 |
| Research and development expenses | 125,280 | 150,745 |
| Capitalization of development expenses | (49,688) | (60,202) |
| Amortization of capitalized development expenses | 12,039 | 15,597 |
| Research and development grants and credits | (321) | (49) |
| Total research and development expenses | 87,310 | 106,091 |
| Impairment of research and development related assets | 1,278 | 4,755 |
| Total | 88,588 | 110,846 |
Paragraphs:
NOTE 23. EXPENSES BY NATURE
Research and development consists of the following:
The impairment expenses in 2018 and 2019 are related to customer specific projects.
The Company’s operations in the Netherlands, Belgium and the United States receive research and development grants and credits from various sources.
Question:
Which countries that the company operates in receive research and development grants and credits?
Answer: Netherlands, Belgium, the United States